Gene_symbol	Gene_Ensembl_ID	Dataset	Disease	x_labels	mean	median	sd	MONDO	RMTL	EFO
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Low-grade glioma/astrocytoma (N = 301)	2.83	2.4	2.09	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Low-grade glioma/astrocytoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Adamantinomatous Craniopharyngioma (N = 20)	1.47	1.5	0.56	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Adamantinomatous Craniopharyngioma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Ewing sarcoma (N = 10)	5.94	4.57	5.56	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	Ewing sarcoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	High-grade glioma/astrocytoma (N = 111)	10.16	4.63	17.95	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	High-grade glioma/astrocytoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Ependymoma (N = 93)	1.36	0.77	1.45	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	Ependymoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	CNS Embryonal tumor (N = 15)	26.97	14.75	32.96	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Blood (N = 755)	1.04	0.8	1.81	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Liver (N = 226)	0.17	0.12	0.2	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Lung (N = 578)	1.52	1.31	1.01	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Testis (N = 361)	32.59	32.61	10.03	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	CNS Embryonal tumor	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Medulloblastoma (N = 122)	27.58	23.85	18.41	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Medulloblastoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Choroid plexus papilloma (N = 16)	0.36	0.34	0.24	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Choroid plexus papilloma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Embryonal tumor with multilayer rosettes (N = 7)	38.41	39.83	28.42	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Blood (N = 755)	1.04	0.8	1.81	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Liver (N = 226)	0.17	0.12	0.2	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Lung (N = 578)	1.52	1.31	1.01	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Testis (N = 361)	32.59	32.61	10.03	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Embryonal tumor with multilayer rosettes	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Neurofibroma/Plexiform (N = 21)	0.48	0.45	0.36	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Blood (N = 755)	1.04	0.8	1.81	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Liver (N = 226)	0.17	0.12	0.2	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Lung (N = 578)	1.52	1.31	1.01	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Testis (N = 361)	32.59	32.61	10.03	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Neurofibroma/Plexiform	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Diffuse midline glioma (N = 68)	9.14	5.84	9.21	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse midline glioma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Meningioma	Meningioma (N = 29)	0.64	0.54	0.47	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Meningioma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Sarcoma (N = 6)	1.49	0.76	1.9	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Sarcoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Atypical Teratoid Rhabdoid Tumor (N = 30)	3.9	1.8	4.19	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Blood (N = 755)	1.04	0.8	1.81	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Liver (N = 226)	0.17	0.12	0.2	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Lung (N = 578)	1.52	1.31	1.01	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Testis (N = 361)	32.59	32.61	10.03	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Diffuse intrinsic pontine glioma (N = 10)	3.8	3.68	1.87	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Diffuse intrinsic pontine glioma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Schwannoma (N = 19)	0.59	0.57	0.2	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Schwannoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Dysembryoplastic neuroepithelial tumor (N = 24)	4.51	4.32	3.28	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Blood (N = 755)	1.04	0.8	1.81	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Liver (N = 226)	0.17	0.12	0.2	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Lung (N = 578)	1.52	1.31	1.01	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Testis (N = 361)	32.59	32.61	10.03	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Dysembryoplastic neuroepithelial tumor	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
GPC2	ENSG00000213420	all_cohorts	Teratoma	Teratoma (N = 8)	1.83	0.58	2.76	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Teratoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Pineoblastoma (N = 5)	10.77	5.31	13.28	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Pineoblastoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Glial-neuronal tumor NOS (N = 7)	5.64	3.42	7.23	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Blood (N = 755)	1.04	0.8	1.81	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Liver (N = 226)	0.17	0.12	0.2	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Lung (N = 578)	1.52	1.31	1.01	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Testis (N = 361)	32.59	32.61	10.03	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Glial-neuronal tumor NOS	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
GPC2	ENSG00000213420	all_cohorts	Chordoma	Chordoma (N = 6)	0.47	0.48	0.14	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Chordoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Craniopharyngioma (N = 15)	1.18	0.42	2.87	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Craniopharyngioma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Neuroblastoma (N = 368)	50.08	37.36	44.8	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Neuroblastoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Wilms tumor (N = 130)	6.42	6.08	3.53	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Blood (N = 755)	1.04	0.8	1.81	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Liver (N = 226)	0.17	0.12	0.2	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Lung (N = 578)	1.52	1.31	1.01	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Testis (N = 361)	32.59	32.61	10.03	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Wilms tumor	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Rhabdoid tumor (N = 64)	4.94	1.07	16.77	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Blood (N = 755)	1.04	0.8	1.81	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Liver (N = 226)	0.17	0.12	0.2	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Lung (N = 578)	1.52	1.31	1.01	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Testis (N = 361)	32.59	32.61	10.03	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Rhabdoid tumor	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Acute Myeloid Leukemia (N = 217)	0.48	0.25	0.74	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Blood (N = 755)	1.04	0.8	1.81	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Liver (N = 226)	0.17	0.12	0.2	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Lung (N = 578)	1.52	1.31	1.01	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Testis (N = 361)	32.59	32.61	10.03	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Myeloid Leukemia	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Acute Lymphoblastic Leukemia (N = 649)	7.76	3.49	12.59	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Blood (N = 755)	1.04	0.8	1.81	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Liver (N = 226)	0.17	0.12	0.2	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Lung (N = 578)	1.52	1.31	1.01	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Testis (N = 361)	32.59	32.61	10.03	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Acute Lymphoblastic Leukemia	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Clear cell sarcoma of the kidney (N = 13)	1.63	1.38	0.96	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Blood (N = 755)	1.04	0.8	1.81	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Liver (N = 226)	0.17	0.12	0.2	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Lung (N = 578)	1.52	1.31	1.01	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Testis (N = 361)	32.59	32.61	10.03	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Clear cell sarcoma of the kidney	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Osteosarcoma (N = 87)	4.18	3.17	5.59	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Adipose - Subcutaneous (N = 663)	1.76	1.66	0.82	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Adipose - Visceral (Omentum) (N = 541)	1.2	1.04	0.65	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Adrenal Gland (N = 258)	0.72	0.63	0.36	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Artery - Aorta (N = 432)	1.45	1.3	0.74	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Artery - Coronary (N = 240)	1.37	1.14	0.95	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Artery - Tibial (N = 663)	0.75	0.61	0.59	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Bladder (N = 21)	1.98	1.85	1.25	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Blood (N = 755)	1.04	0.8	1.81	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Amygdala (N = 152)	2.29	2.22	0.86	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	1.86	1.78	0.65	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Caudate (basal ganglia) (N = 246)	1.35	1.35	0.5	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Cerebellum (N = 456)	3.2	2.78	1.91	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Cortex (N = 255)	1.63	1.53	0.57	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Frontal Cortex (BA9) (N = 209)	1.61	1.56	0.59	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Hippocampus (N = 197)	2.21	2.09	1	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Hypothalamus (N = 202)	1.58	1.45	0.83	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	1.36	1.28	0.69	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Putamen (basal ganglia) (N = 205)	1.32	1.24	0.58	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Spinal cord (cervical c-1) (N = 159)	3.34	3.2	1.52	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Brain - Substantia nigra (N = 139)	1.74	1.59	0.96	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Breast - Mammary Tissue (N = 459)	2.27	1.88	1.62	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Cells - Cultured fibroblasts (N = 504)	1.3	1.21	0.6	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Cells - EBV-transformed lymphocytes (N = 174)	2.61	2.33	1.56	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Cervix - Ectocervix (N = 9)	4.63	3.68	2.91	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Cervix - Endocervix (N = 10)	5.14	3.64	4.09	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Colon - Sigmoid (N = 373)	1.67	1.55	0.83	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Colon - Transverse (N = 406)	2.02	1.92	0.87	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Esophagus - Gastroesophageal Junction (N = 375)	1.13	0.99	0.61	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Esophagus - Mucosa (N = 555)	1.16	1.04	0.59	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Esophagus - Muscularis (N = 515)	1.19	1.05	0.65	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Fallopian Tube (N = 9)	3.32	2.8	1.75	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Heart - Atrial Appendage (N = 429)	0.63	0.56	0.36	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Heart - Left Ventricle (N = 432)	0.44	0.34	0.42	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Kidney - Cortex (N = 85)	0.66	0.48	0.75	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Liver (N = 226)	0.17	0.12	0.2	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Lung (N = 578)	1.52	1.31	1.01	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Minor Salivary Gland (N = 162)	2.06	1.84	1.2	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Muscle - Skeletal (N = 803)	0.45	0.34	0.4	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Nerve - Tibial (N = 619)	3	2.89	1.11	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Ovary (N = 180)	5.42	4.51	3.52	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Pancreas (N = 328)	0.33	0.26	0.32	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Pituitary (N = 283)	2.24	2.04	1.12	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Prostate (N = 245)	2.24	2.08	1.05	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	13.99	13.12	6.07	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Skin - Sun Exposed (Lower leg) (N = 701)	10.98	10.5	4.54	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Small Intestine - Terminal Ileum (N = 187)	2.74	2.13	2	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Spleen (N = 241)	3.1	2.8	1.43	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Stomach (N = 359)	0.76	0.65	0.46	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Testis (N = 361)	32.59	32.61	10.03	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Thyroid (N = 653)	1.07	0.95	0.6	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Uterus (N = 142)	6.07	4.65	4.41	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
GPC2	ENSG00000213420	all_cohorts	Osteosarcoma	Vagina (N = 156)	3.16	2.98	1.37	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Low-grade glioma/astrocytoma (N = 301)	2.3	1.95	2.15	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Low-grade glioma/astrocytoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0016685	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Adamantinomatous Craniopharyngioma (N = 20)	6.66	6.38	4.07	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Adamantinomatous Craniopharyngioma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000069
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Ewing sarcoma (N = 10)	3.6	3.4	3.13	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	Ewing sarcoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0012817	Relevant Molecular Target (RMTL version 1.0)	EFO_0000174
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	High-grade glioma/astrocytoma (N = 111)	10.75	3.72	19.45	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	High-grade glioma/astrocytoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0100342	Relevant Molecular Target (RMTL version 1.0)	EFO_0005543
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Ependymoma (N = 93)	5.06	2.35	13.92	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	Ependymoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0016698	Relevant Molecular Target (RMTL version 1.0)	EFO_1000028
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	CNS Embryonal tumor (N = 15)	78.12	17.92	200.24	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Blood (N = 755)	0.05	0.03	0.08	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Liver (N = 226)	0.48	0.13	1.12	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Lung (N = 578)	0.69	0.29	1.5	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Testis (N = 361)	6.66	6.82	1.7	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	CNS Embryonal tumor	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0018843	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Medulloblastoma (N = 122)	25.3	5.74	53.83	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Medulloblastoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0007959	Relevant Molecular Target (RMTL version 1.0)	EFO_0002939
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Choroid plexus papilloma (N = 16)	1.59	1.1	1.39	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Choroid plexus papilloma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0009837	Relevant Molecular Target (RMTL version 1.0)	EFO_1000177
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Embryonal tumor with multilayer rosettes (N = 7)	37.86	22.03	51.13	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Blood (N = 755)	0.05	0.03	0.08	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Liver (N = 226)	0.48	0.13	1.12	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Lung (N = 578)	0.69	0.29	1.5	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Testis (N = 361)	6.66	6.82	1.7	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Embryonal tumor with multilayer rosettes	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0016715	Relevant Molecular Target (RMTL version 1.0)	EFO_0005784
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Neurofibroma/Plexiform (N = 21)	0.91	0.22	2.51	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Blood (N = 755)	0.05	0.03	0.08	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Liver (N = 226)	0.48	0.13	1.12	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Lung (N = 578)	0.69	0.29	1.5	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Testis (N = 361)	6.66	6.82	1.7	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Neurofibroma/Plexiform	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0003304	Relevant Molecular Target (RMTL version 1.0)	EFO_0000658
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Diffuse midline glioma (N = 68)	8.4	4.44	13.82	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse midline glioma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Meningioma	Meningioma (N = 29)	0.14	0.1	0.16	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Meningioma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0016642	Relevant Molecular Target (RMTL version 1.0)	EFO_0003851
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Sarcoma (N = 6)	0.82	0.1	1.76	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Sarcoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0005089	Relevant Molecular Target (RMTL version 1.0)	EFO_0000691
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Atypical Teratoid Rhabdoid Tumor (N = 30)	6.22	1.28	9.89	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Blood (N = 755)	0.05	0.03	0.08	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Liver (N = 226)	0.48	0.13	1.12	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Lung (N = 578)	0.69	0.29	1.5	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Testis (N = 361)	6.66	6.82	1.7	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Atypical Teratoid Rhabdoid Tumor	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0020560	Relevant Molecular Target (RMTL version 1.0)	EFO_1002008
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Diffuse intrinsic pontine glioma (N = 10)	3.87	3.24	2.48	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Diffuse intrinsic pontine glioma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0006033	Relevant Molecular Target (RMTL version 1.0)	EFO_1000026
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Schwannoma (N = 19)	0.89	0.37	0.99	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Schwannoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0002546	Relevant Molecular Target (RMTL version 1.0)	EFO_0000693
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Dysembryoplastic neuroepithelial tumor (N = 24)	4.06	3.26	3.23	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Blood (N = 755)	0.05	0.03	0.08	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Liver (N = 226)	0.48	0.13	1.12	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Lung (N = 578)	0.69	0.29	1.5	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Testis (N = 361)	6.66	6.82	1.7	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Dysembryoplastic neuroepithelial tumor	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0005505	Relevant Molecular Target (RMTL version 1.0)	EFO_0005551
MYCN	ENSG00000134323	all_cohorts	Teratoma	Teratoma (N = 8)	2.2	0.71	3.27	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Teratoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0002601	Relevant Molecular Target (RMTL version 1.0)	EFO_0000514
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Pineoblastoma (N = 5)	10.77	14.31	6.76	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Pineoblastoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0016722	Relevant Molecular Target (RMTL version 1.0)	EFO_1000475
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Glial-neuronal tumor NOS (N = 7)	4.78	3.42	3.45	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Blood (N = 755)	0.05	0.03	0.08	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Liver (N = 226)	0.48	0.13	1.12	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Lung (N = 578)	0.69	0.29	1.5	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Testis (N = 361)	6.66	6.82	1.7	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Glial-neuronal tumor NOS	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0016729	Relevant Molecular Target (RMTL version 1.0)	EFO_0003833
MYCN	ENSG00000134323	all_cohorts	Chordoma	Chordoma (N = 6)	0.36	0.16	0.48	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Chordoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0008978	Relevant Molecular Target (RMTL version 1.0)	EFO_0003820
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Craniopharyngioma (N = 15)	0.94	0.5	1.36	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Craniopharyngioma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0002787	Relevant Molecular Target (RMTL version 1.0)	EFO_1000209
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Neuroblastoma (N = 368)	112.47	23.35	301.55	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Neuroblastoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0005072	Relevant Molecular Target (RMTL version 1.0)	EFO_0000621
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Wilms tumor (N = 130)	72.52	65.32	42.51	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Blood (N = 755)	0.05	0.03	0.08	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Liver (N = 226)	0.48	0.13	1.12	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Lung (N = 578)	0.69	0.29	1.5	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Testis (N = 361)	6.66	6.82	1.7	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Wilms tumor	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0006058	Relevant Molecular Target (RMTL version 1.0)	EFO_0003865
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Rhabdoid tumor (N = 64)	47.63	0.11	364.67	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Blood (N = 755)	0.05	0.03	0.08	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Liver (N = 226)	0.48	0.13	1.12	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Lung (N = 578)	0.69	0.29	1.5	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Testis (N = 361)	6.66	6.82	1.7	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Rhabdoid tumor	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0002728	Relevant Molecular Target (RMTL version 1.0)	EFO_0005701
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Acute Myeloid Leukemia (N = 217)	9.88	3.88	17.94	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Blood (N = 755)	0.05	0.03	0.08	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Liver (N = 226)	0.48	0.13	1.12	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Lung (N = 578)	0.69	0.29	1.5	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Testis (N = 361)	6.66	6.82	1.7	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Myeloid Leukemia	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0018874	Relevant Molecular Target (RMTL version 1.0)	EFO_0000222
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Acute Lymphoblastic Leukemia (N = 649)	3.32	0.34	17.88	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Blood (N = 755)	0.05	0.03	0.08	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Liver (N = 226)	0.48	0.13	1.12	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Lung (N = 578)	0.69	0.29	1.5	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Testis (N = 361)	6.66	6.82	1.7	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Acute Lymphoblastic Leukemia	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0004967	Relevant Molecular Target (RMTL version 1.0)	EFO_0000220
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Clear cell sarcoma of the kidney (N = 13)	2.66	2.36	0.65	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Blood (N = 755)	0.05	0.03	0.08	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Liver (N = 226)	0.48	0.13	1.12	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Lung (N = 578)	0.69	0.29	1.5	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Testis (N = 361)	6.66	6.82	1.7	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Clear cell sarcoma of the kidney	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0005006	Relevant Molecular Target (RMTL version 1.0)	EFO_0000350
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Osteosarcoma (N = 87)	0.79	0.42	1.5	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Adipose - Subcutaneous (N = 663)	0.81	0.43	1.49	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Adipose - Visceral (Omentum) (N = 541)	0.41	0.25	0.49	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Adrenal Gland (N = 258)	0.43	0.24	0.62	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Artery - Aorta (N = 432)	0.35	0.25	0.33	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Artery - Coronary (N = 240)	1.06	0.7	1.26	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Artery - Tibial (N = 663)	0.37	0.2	0.54	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Bladder (N = 21)	1.03	0.73	0.76	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Blood (N = 755)	0.05	0.03	0.08	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Amygdala (N = 152)	2.43	2.09	1.48	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Anterior cingulate cortex (BA24) (N = 176)	2.48	2.18	1.27	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Caudate (basal ganglia) (N = 246)	1.74	1.57	0.96	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Cerebellum (N = 456)	1.01	0.96	0.52	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Cortex (N = 255)	2.84	2.68	1.3	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Frontal Cortex (BA9) (N = 209)	2.66	2.44	1.52	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Hippocampus (N = 197)	3.46	2.93	2.19	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Hypothalamus (N = 202)	2.88	2.56	1.75	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Nucleus accumbens (basal ganglia) (N = 246)	2.38	2.27	1.37	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Putamen (basal ganglia) (N = 205)	1.72	1.37	1.39	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Spinal cord (cervical c-1) (N = 159)	6.42	5.62	4.01	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Brain - Substantia nigra (N = 139)	3.14	2.59	2.25	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Breast - Mammary Tissue (N = 459)	0.67	0.43	0.8	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Cells - Cultured fibroblasts (N = 504)	0.01	0	0.03	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Cells - EBV-transformed lymphocytes (N = 174)	0.02	0	0.03	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Cervix - Ectocervix (N = 9)	0.92	0.58	0.75	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Cervix - Endocervix (N = 10)	1.08	1.08	0.54	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Colon - Sigmoid (N = 373)	0.69	0.58	0.47	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Colon - Transverse (N = 406)	0.85	0.63	0.74	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Esophagus - Gastroesophageal Junction (N = 375)	0.72	0.6	0.58	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Esophagus - Mucosa (N = 555)	0.95	0.75	0.75	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Esophagus - Muscularis (N = 515)	0.73	0.55	0.6	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Fallopian Tube (N = 9)	0.65	0.56	0.26	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Heart - Atrial Appendage (N = 429)	0.45	0.32	0.5	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Heart - Left Ventricle (N = 432)	0.36	0.23	0.41	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Kidney - Cortex (N = 85)	1.59	1.02	1.75	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Liver (N = 226)	0.48	0.13	1.12	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Lung (N = 578)	0.69	0.29	1.5	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Minor Salivary Gland (N = 162)	6.39	4.85	5.7	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Muscle - Skeletal (N = 803)	0.14	0.09	0.17	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Nerve - Tibial (N = 619)	8.16	7.52	4.16	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Ovary (N = 180)	4.08	2.95	3.87	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Pancreas (N = 328)	0.12	0.08	0.14	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Pituitary (N = 283)	0.52	0.36	0.48	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Prostate (N = 245)	0.3	0.2	0.35	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Skin - Not Sun Exposed (Suprapubic) (N = 604)	2.16	0.58	4.87	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Skin - Sun Exposed (Lower leg) (N = 701)	1.4	0.63	2.42	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Small Intestine - Terminal Ileum (N = 187)	1.28	1.16	0.6	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Spleen (N = 241)	0.54	0.31	0.86	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Stomach (N = 359)	2.55	1.95	2.36	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Testis (N = 361)	6.66	6.82	1.7	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Thyroid (N = 653)	5.78	5.02	3.6	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Uterus (N = 142)	0.66	0.53	0.51	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
MYCN	ENSG00000134323	all_cohorts	Osteosarcoma	Vagina (N = 156)	0.88	0.61	0.88	MONDO_0009807	Relevant Molecular Target (RMTL version 1.0)	EFO_0000637
